Fact-checked by Grok 2 weeks ago

Clethodim

Clethodim is a selective, post-emergence cyclohexanedione herbicide developed by Chevron Chemical Company in 1987 and first registered for use in the United States in 1992, primarily employed to control annual and perennial grass weeds in broadleaf crops such as soybeans, cotton, peanuts, sugar beets, potatoes, and alfalfa. Its chemical formula is C₁₇H₂₆ClNO₃S, with the IUPAC name (2E)-2-[1-[[(E)-3-chloroprop-2-enoxyimino]propyl]-5-[2-(ethylsulfanyl)propyl]-3-hydroxycyclohex-2-en-1-one, and it is typically formulated as an emulsifiable concentrate for foliar application. Clethodim functions by inhibiting the (ACCase), which disrupts biosynthesis in susceptible grasses, leading to cessation of growth and eventual plant death, while exhibiting selectivity for broadleaf crops due to differences in sensitivity. Physically, it appears as a clear pale with a of -80°C, high water solubility (up to 58.9 g/L at pH 9 and 20°C), low volatility (vapor pressure of 2.1 × 10⁻⁶ at 20°C), and moderate mobility in , where it degrades rapidly with a of approximately 0.54 days under aerobic conditions. In terms of safety, clethodim is classified by the U.S. Environmental Protection Agency as having low to humans (Toxicity Category III for oral and eye , IV for dermal and ), with no evidence of carcinogenicity, , or immunotoxicity, and it is not likely to pose significant risks from dietary, residential, or occupational exposures when used according to label directions. Environmentally, it shows moderate toxicity to birds and fish, low to and , and low persistence in and water.

Chemical Identity and Properties

Molecular Structure and Formula

Clethodim is a selective herbicide belonging to the cyclohexanedione family, classified under HRAC Group 1 for its inhibition of acetyl-CoA carboxylase (ACCase). This class, also known as cyclohexanediones (DIMs), features a core cyclohexenone structure that is characteristic of post-emergence grass herbicides. The chemical name of clethodim is (±)-2-[(E)-1-[(E)-3-chloroallyloxyimino]propyl]-5-[2-(ethylthio)propyl]-3-hydroxycyclohex-2-enone, reflecting its complex substituted cyclohexenone backbone. Its molecular formula is C_{17}H_{26}ClNO_{3}S, with a molecular weight of 359.91 g/mol. The compound is identified by CAS number 99129-21-2. At the molecular level, clethodim consists of a cyclohex-2-en-1-one ring bearing a at position 3, an allyloxyimino-substituted propyl chain at position 2, and a 2-(ethylthio)propyl at position 5. The allyloxyimino moiety specifically includes a 3-chloroallyl group with (E)-configuration at both the (C=N) and the allylic . Clethodim exists as a of at the chiral center in the ring, though the (-)- exhibits greater herbicidal activity. This contributes to its selectivity and efficacy against grassy weeds while sparing broadleaf crops.

Physical and Chemical Characteristics

Clethodim is typically observed as a colorless to brown oily liquid, with variations in color depending on purity and formulation; technical-grade material often appears as a viscous or pale yellow liquid. The compound exhibits pH-dependent in , ranging from 0.053 g/L at 4 to 58.9 g/L at 9 (e.g., 5.45 g/L at 7), all at 20°C. It is highly soluble in acetone (900 g/L at 20°C) and most organic solvents such as , , and (>200–900 g/L at 20–25°C), but shows low in non-polar solvents like or (0.3 g/L at 20°C). Clethodim has low , characterized by a of approximately 2.1 × 10^{-6} at 20°C, indicating minimal tendency to evaporate under standard conditions. As a weak acid attributed to its group, clethodim has a of 4.47 at 20–25°C, influencing its and behavior in aqueous environments. stability is pH-dependent, with longer-term studies showing DT_{50} values of 28–41 days at 5 and stability exceeding 300 days at 7 and 9 at 25°C. The molecule contains chromophores, including the chloroallyloxyimino and ethylthio groups, that absorb UV above 290 , rendering it susceptible to photolysis with half-lives ranging from 1.5–6.8 days in aqueous solutions under simulated , depending on . Its (log K_{ow}) is 4.2 for the non-dissociated form, indicating moderate that affects partitioning between aqueous and organic phases.

Synthesis and Production

The synthesis of clethodim involves a multi-step process that constructs the cyclohexenone core and attaches key functional groups, beginning with the Michael addition of ethyl mercaptan to (crotonal) to form 3-(ethylthio)butanal. This intermediate undergoes with acetone under basic conditions to yield 4-(ethylthio)pentan-2-one, which is then treated with in a subsequent Michael addition, followed by and to introduce the malonate-derived carbon chain. The resulting diketone precursor cyclizes under acidic or basic catalysis to form the key intermediate 5-[2-(ethylthio)propyl]-3-hydroxycyclohex-2-enone. In the final step, this intermediate is acylated at the 2-position with or a similar to generate the 2-propionyl derivative, which then undergoes oximation via with O-(3-chloroprop-2-en-1-yl) (3-chloroallyloxyamine) in the presence of a base such as , yielding clethodim as the (E)- predominantly. This is typically conducted in or at ambient , with times of 1-2 days, and the product is isolated by acidification and extraction. Commercial production of clethodim, originally developed by Chemical Company, follows optimized versions of this route, emphasizing efficient cyclohexenone core assembly through the malonate-mediated cyclization and selective oximation to minimize byproducts. The process has been scaled up by successor manufacturers including Arysta LifeScience (now part of UPL), with key steps achieving typical industrial yields of 70-85% after purification, though cyclization yields can vary to around 65% in continuous flow adaptations. The original synthesis was patented in 1984 by (US Patent 4,440,566, filed 1982), with related international filings such as GB 2,090,246 confirming the core methodology. Recent kinetic studies on the final condensation step have focused on thermal hazards, employing to determine an of approximately 47 kJ/mol and a of 1.72 × 10^4 L mol⁻¹ s⁻¹, enabling safer with controlled exothermicity below 100 kJ/mol. These optimizations support high-purity output (>95%) for agricultural formulations, prioritizing scalability over exhaustive in the racemic product.

History and Development

Discovery and Patenting

Clethodim was developed by researchers at Chemical Company during the mid-1980s as part of a broader effort to create selective post-emergence herbicides within the cyclohexanedione family, targeting grassy weeds while sparing broadleaf crops. This work built on earlier discoveries of (ACCase) inhibitors, aiming to provide effective control of annual and perennial grasses in row crops like soybeans and , where non-selective options like limited flexibility in integrated weed management. The compound, with the development code RE-45601, emerged from systematic synthesis and screening of oxyimino-substituted cyclohexanediones for enhanced potency and crop safety. The key intellectual property milestone for clethodim was secured through U.S. RE32,489 (granted September 1, 1987), a of the original U.S. No. 4,440,566 (granted April 3, 1984), which covered the , , and herbicidal applications of the compound and related analogs. Filed as a continuation-in-part from an earlier 1982 application by Research Company (later USA Inc.), the detailed the preparation of haloalkenyl-substituted derivatives like clethodim, emphasizing their efficacy against grassy weeds at rates of 0.2 to 6 kg/ha in pre- and post-emergent uses. A corresponding international , GB 2090246 (granted December 5, 1984), was also secured by , reinforcing global protection for the technology. Initial field evaluations of clethodim began in 1986, with trials demonstrating strong efficacy against annual grasses such as barnyardgrass and foxtail in fields, achieving over 90% control at application rates of 0.1 to 0.25 kg ai/ha without significant injury to the crop. These early tests, reported in proceedings from the 1987 British Crop Protection Conference, confirmed the compound's selectivity and rapid action, paving the way for further refinement in formulation and application timing. In 1988, and formed Valent U.S.A. as a to handle agricultural chemicals, including clethodim. Chevron sold its stake to Sumitomo in 1991, making Valent a wholly owned , which continued refinements in enantiomeric purity and compatibility in the and , including developments leading to the Select Max formulation.

Commercial Introduction and Manufacturers

Clethodim was commercially introduced in 1991 under the Select by Chemical Company (through Valent U.S.A.), marking its entry into the agricultural market as a selective post-emergence for grass . Developed initially by in the late , the product was managed under the Valent U.S.A. and subsequent full ownership by . This launch followed patent protections established in the early , enabling introduction to the market for broadleaf crops. By the mid-1990s, clethodim experienced rapid adoption in the United States, particularly in and farming, coinciding with the rise of herbicide-tolerant genetically modified varieties that expanded post-emergence application opportunities. Farmers valued its efficacy against annual and perennial grasses without harming broadleaf crops, contributing to integrated weed management practices in these key row crops. Today, Valent U.S.A. (a subsidiary of Sumitomo Chemical) serves as the primary developer and supplier of branded formulations like Select Max. BASF supplies clethodim formulations such as Clethodim IH 240 in certain markets. Generic versions are produced by companies such as Albaugh, which offers Clethodim 2E, and Sipcam Oxon, providing specialized 180 g/L concentrations for post-emergence grass control. In China, producers like CIE Chemical contribute to the supply chain with technical and formulated products, supporting export markets. The global market for clethodim reached approximately USD 581 million in sales in 2022 and is projected to grow to USD 954 million by 2030, reflecting a compound annual growth rate (CAGR) of 6.4% driven by demand in herbicide-tolerant cropping systems. Common formulations include 240 g/L emulsifiable concentrates, such as Clethodim 2E, which contains 26.4% and is designed for foliar application in various crops. These EC formulations ensure effective systemic uptake while maintaining compatibility with mixes for broad-spectrum .

Agricultural Uses

Target Weeds and Application Methods

Clethodim effectively controls a broad spectrum of annual and perennial grass weeds but does not affect sedges or broadleaf species. Among annual grasses, it targets common problematic species such as foxtail (Setaria spp.), barnyardgrass (Echinochloa crus-galli), and crabgrass (Digitaria spp.), which are frequent invaders in row crops and turf. For perennial grasses, clethodim suppresses or eliminates established species including quackgrass (Elymus repens), johnsongrass (Sorghum halepense), and bermudagrass (Cynodon dactylon), often requiring sequential applications for rhizomatous perennials to prevent regrowth. Applications are made post-emergence as a foliar spray to actively growing grasses under favorable conditions, such as adequate and temperatures between 15–27°C, to maximize uptake and efficacy. Optimal timing targets weeds at the 2- to 6-leaf stage (corresponding to heights of 5–20 cm for most annuals), as larger or stressed plants exhibit reduced control. , excessive heat, or cold can impair performance, so or rainfall within a few days prior is recommended. Recommended rates vary from 0.105 to 0.28 kg per , with lower rates (0.105–0.14 kg /) sufficient for small annual grasses and higher rates (up to 0.28 kg /) needed for perennials or dense infestations. Ground applications use spray volumes of 40–150 L/ at 200–400 kPa pressure with flat-fan nozzles for uniform coverage, while aerial methods employ 20–100 L/ to ensure droplet penetration. Adjuvants are essential for enhancing leaf penetration and ; crop oil concentrate at 1% v/v (minimum 0.5 L/) or non-ionic at 0.25% v/v is required, often combined with (2–4 kg/) for challenging species like quackgrass. As a member of HRAC (ACCase inhibitors), clethodim carries a high risk of development, necessitating rotation with herbicides from other modes of action and integration with cultural practices like or diverse crop rotations. Multiple cases of ACCase in grasses, including spp. and spp., have been documented since the 2000s, with recent confirmations as of 2025 including in annual bluegrass () in (first global case), Italian ryegrass () in , and goosegrass () in and , often involving target-site mutations or enhanced metabolism, underscoring the importance of scouting for poor control and avoiding over-reliance on chemistries.

Compatible Crops and Formulations

Clethodim is selectively used in a range of broadleaf crops where it provides effective without significant injury to the crop. Primary compatible crops include soybeans, , , sugar beets, , potatoes, and various such as tomatoes, , , , carrots, , cucumbers, eggplants, and peppers. It is also labeled for use in specialty broadleaf crops like sunflowers, safflowers, , , , strawberries, , and non-bearing fruit trees including apples, pears, apricots, and cherries. Additionally, clethodim finds application in ornamental plants such as azaleas, roses, and ground covers, as well as non-crop areas like rights-of-way and fields, but it is not suitable for cereal grains or other grass crops due to its activity on gramineous . Clethodim is commercially available in formulations such as and microemulsions, which enhance its and application efficacy. Common products include Select Max from Valent U.S.A. Corporation at a concentration of approximately 120 g/L clethodim, and from at 240 g/L (2 lbs ai/). These formulations are typically applied postemergence with the addition of crop concentrate or non-ionic to improve . Tank-mix compatibility allows clethodim to be combined with many broadleaf herbicides, such as , 2,4-DB, and bentazon, for broader spectrum in labeled crops, provided a jar test confirms physical . However, mixtures with acetolactate synthase () inhibitors should be avoided, as they may reduce clethodim's efficacy on grasses. Fungicides and insecticides are generally compatible, though some may cause minor or require adjusted rates. Label restrictions emphasize safe use practices, with a maximum seasonal rate of 0.56 kg per (0.5 lbs ai/A) across most to prevent residue accumulation. Pre-harvest intervals vary by (e.g., 60 days for soybeans, 20 days for tomatoes), and while many crops have no or feeding restrictions post-application, others like require a 15-day wait before treated . Applications should avoid within one hour and adhere to the most restrictive guidelines in tank mixes.

Mechanism of Action

Biochemical Inhibition Process

Clethodim acts as a selective by targeting the () , which catalyzes the first committed step in in . Specifically, it inhibits the plastidic homomeric isoform of ACCase found predominantly in grasses ( family), to the carboxyltransferase (CT) domain of the and blocking the reaction. This prevents the of to form , a critical precursor for chain elongation. The inhibition of ACCase disrupts lipid synthesis essential for membrane formation and maintenance, leading to a rapid depletion of phospholipids and galactolipids in membranes. Consequently, this causes instability, leakage of cellular contents, and the cessation of and elongation, particularly in meristematic tissues where growth is active. Visible symptoms, such as (yellowing) followed by (tissue death) in young leaves and growing points, typically appear 7 to 14 days after application, reflecting the systemic and slow-acting nature of clethodim compared to contact herbicides that cause immediate damage. Clethodim is classified by the Herbicide Resistance Action Committee (HRAC) as (legacy ), indicating its as an ACCase inhibitor, which places it in the same category as other cyclohexanedione (DIM) and aryloxyphenoxypropionate () herbicides. This shared often results in cross-resistance among grass weeds, such as resistance to clethodim conferred by target-site mutations (e.g., Ile1781Leu) that also affect efficacy of related inhibitors like sethoxydim. In plants, clethodim undergoes rapid oxidation primarily via enzymes to form clethodim , the principal responsible for herbicidal activity, and further to clethodim , which retains some activity. These and forms contribute to the overall efficacy by maintaining inhibition of ACCase even as the parent compound degrades.

Absorption and Selectivity

Clethodim is primarily absorbed through foliar uptake following post-emergence application, exhibiting a biphasic pattern in susceptible grasses, with 61% of the applied radiolabeled compound absorbed within the first 8 hours and an additional 24 percentage points by 96 hours after treatment. This initial rapid is followed by a slower secondary , influenced by and environmental conditions, where most of the absorbed clethodim remains in the treated . Once absorbed, clethodim translocates systemically via the , moving both acropetally toward growing shoots and basipetally toward , with accumulation primarily at meristematic tissues such as growing points. In studies on bermudagrass, 79 to 100% of absorbed clethodim stayed in the treated , while 3 to 14% moved to untreated shoots and less than 8% reached , highlighting its targeted mobility to metabolic sinks. The selectivity of clethodim for grasses over broadleaf crops stems from differences in (ACCase) isoforms: grasses possess a sensitive plastidic (eukaryotic) form, while broadleaves have a tolerant plastidic heteromeric (prokaryotic-like) form that is less susceptible to inhibition. Additionally, broadleaf rapidly detoxify clethodim through metabolism by enzymes, further enhancing tolerance. Absorption and efficacy are enhanced by adjuvants such as crop oil concentrates or , which improve penetration, but clethodim performance declines in cool or wet conditions due to reduced and translocation. Frost or low temperatures, for instance, have been shown to decrease control in resistant ryegrass populations by impairing movement. to clethodim in some grass populations arises from target-site mutations in the ACCase , such as isoleucine-1781-leucine, aspartate-2078-glycine, and isoleucine-2041-asparagine, which reduce binding and confer varying levels of . These mutations have been documented in species like rigidum and , complicating management in agricultural settings. As of 2025, has been documented in Italian ryegrass populations in the United States, with varying levels detected in regional screenings.

Environmental Fate and Impact

Degradation Pathways

Clethodim primarily undergoes in through under aerobic conditions, with half-lives (DT50) of 1.2–2.5 days for the parent compound at 25°C depending on type and environmental factors. In specific aerobic studies at 20–25°C, the DT50 for clethodim is approximately 3 days, reflecting rapid breakdown facilitated by microorganisms. Under conditions, such as in flooded s, degradation slows significantly, with a DT50 of about 20 days. In aquatic environments, clethodim degrades via and photolysis. at 5 yields a DT50 of 28 days at 25°C, producing major metabolites such as clethodim oxazole (up to 51% of applied radioactivity) and 3-chloroallyl (up to 31%). At higher levels (7–9), is slower, with DT50 values exceeding 300 days. Photolysis in accelerates degradation, with half-lives of approximately 1 day under simulated , leading to similar polar products including oxazole derivatives. The key metabolites of clethodim include the active clethodim sulfoxide, formed via initial oxidation, which further degrades to clethodim sulfone. Ultimate degradation products are polar compounds, such as bound residues, , and chloride ions, resulting from ring-opening and mineralization processes in and . Clethodim exhibits low bioaccumulation potential in aquatic organisms, with bioconcentration factors (BCF) in fish ranging from 2 to 4. This low BCF, confirmed in studies with bluegill sunfish, indicates minimal uptake and rapid depuration from tissues.

Mobility and Persistence in Ecosystems

Clethodim exhibits moderate mobility in soil, with organic carbon partition coefficients (Koc) typically ranging from 100 to 300 L/kg, indicating potential for leaching in sandy or low-organic-matter soils under high rainfall conditions. However, its rapid degradation generally confines movement to shallow depths, with maximum soil penetration observed up to 36 inches but concentrations decreasing sharply below the top 12 inches (averaging 2.54 ppm in the upper layer). This limited vertical transport reduces the risk of deep soil contamination, as binding to soil organic matter further immobilizes the compound in finer-textured soils. Groundwater contamination from clethodim is considered low risk, with monitoring studies reporting concentrations below 0.1 µg/L and no significant detections attributed to the parent compound. However, in 2024 monitoring in , clethodim metabolites ( and ) were detected for the first time in . Modeled estimates using tools like PRZM-GW predict peak levels up to 29 µg/L and SCIGROW up to 39 µg/L under worst-case scenarios involving multiple applications, but actual field data confirm negligible accumulation due to the herbicide's short residence time. Atmospheric transport of clethodim is negligible, owing to its low (<1 × 10⁻⁷ mm Hg at 25°C), which prevents significant volatilization from or surfaces. Spray drift during application represents the primary aerial pathway, but deposition is minimal beyond the area, with losses estimated at less than 0.014% of the applied rate. In terms of persistence, clethodim has a field half-life of 8 to 45 days, varying with environmental factors such as , , and microbial activity, though aerobic studies often show shorter times of 1.2 to 2.5 days for the parent compound. This relatively brief duration results in minimal accumulation in ecosystems, as the metabolizes quickly without forming persistent bound residues. Within systems, clethodim's half-life ranges from 1 to 14 days, further limiting long-term exposure. Ecosystem exposure primarily occurs through following rainfall events shortly after application, potentially introducing clethodim to nearby bodies at concentrations up to 1.2 µg/L in modeled scenarios. However, dilution in receiving waters and rapid ( of 7 days on surfaces) ensure that peak levels decline swiftly, with annual average stream concentrations typically below 13 µg/L and no evidence of in non-target organisms.

Toxicology and Safety

Effects on Humans and Mammals

Clethodim exhibits low to mammals, with oral LD50 values of 1,630 mg/kg in male rats and 1,360 mg/kg in female rats, classifying it in EPA III. Dermal LD50 exceeds 5,000 mg/kg in rabbits, placing it in IV, indicating minimal through the . However, clethodim causes moderate ( III) and mild eye ( III), potentially leading to reversible or conjunctival redness in exposed individuals. exposure is low , with an LC50 greater than 3.9 mg/L (4-hour exposure) in rats, though lower values around 2.0 mg/L have been reported in some formulations, emphasizing risks from spray mist or vapor. Chronic exposure studies demonstrate low , with a (NOAEL) of 21 mg/kg/day identified in a 2-year carcinogenicity study, based on effects like increased liver weights at higher doses. Clethodim is not carcinogenic to humans, showing no evidence of tumor formation in rats or mice at doses up to 150 mg/kg/day. It lacks mutagenic potential, with negative results in gene assays and chromosomal aberration tests. Reproductive and developmental is absent, as multi-generation studies reported no effects on , offspring viability, or fetal development at doses up to 263 mg/kg/day. Primary exposure routes for humans and mammals include occupational dermal contact and via spray drift during application, as well as incidental oral from contaminated or water. Clethodim metabolizes rapidly in mammals, with the primary clethodim sulfoxide being less toxic than the parent compound and comprising 48-68% of residues; other metabolites like clethodim sulfone show similar low toxicity profiles. The U.S. EPA has determined that clethodim does not share a common mechanism of toxicity with other s, precluding cumulative risk assessments. To mitigate risks, (PPE) such as chemical-resistant gloves, protective eyewear, long-sleeved shirts, long pants, and shoes plus socks is required during handling and application. A restricted entry interval () of 12 hours is mandated post-application to prevent re-entry into treated areas without PPE.

Ecotoxicological Effects

Clethodim demonstrates moderate acute toxicity to fish and low to moderate toxicity to algae and aquatic invertebrates. Acute LC50 values include 25 mg/L for rainbow trout (Oncorhynchus mykiss) and 35.1 mg/L ErC50 for Pseudokirchneriella subcapitata. Chronic exposure poses risks to reproduction and development in aquatic organisms, exemplified by a NOEC of 0.94 mg/L for Daphnia magna in 21-day reproduction tests and 0.01 mg/L for fathead minnow in chronic studies. These effects stem from clethodim's interference with lipid synthesis, disrupting cellular functions in exposed organisms. In avian species, clethodim exhibits low , with oral LD50 values exceeding 2,000 mg/kg body weight in bobwhite quail and greater than 2,250 mg/kg in mallard ducks. Dietary subacute LC50 values are similarly high, surpassing 5,620 mg/kg for both species, indicating minimal risk from direct exposure or secondary poisoning. Clethodim shows no significant potential in birds due to its moderate log Kow of 2.57 and rapid . Clethodim is practically non-toxic to bees via acute contact exposure, with LD50 values greater than 100 µg per bee, though chronic dietary effects may warrant caution during flowering periods to minimize residue transfer. As a selective graminicide, clethodim primarily targets grass weeds and poses low risk to non-target broadleaf plants, which exhibit tolerance through reduced absorption and enhanced metabolic detoxification. Overall, clethodim is classified under GHS as toxic to aquatic life with long-lasting effects (H411), driven by its persistence in and relative to application rates, necessitating protective measures near water bodies. In contrast, risks to organisms remain low, as evidenced by LC50 values of 27 mg/kg dry , well above typical levels.

Regulatory Status

Approvals and Tolerances

Clethodim was first registered by the (EPA) in 1992 as a post-emergence for use on various crops and non-crop areas. Current EPA tolerances for residues of clethodim and its metabolites, calculated as the stoichiometric equivalent of clethodim, range from 0.05 to 20 mg/kg across numerous commodities, with specific limits including 10 mg/kg for soybeans, 1 mg/kg for the cottonseed subgroup 20C, and 0.05 mg/kg for . These tolerances support its use on crops such as , , and sugar beets while ensuring dietary exposure remains below established safety thresholds. In the , clethodim has been approved as an active substance under Regulation (EC) No 1107/2009, following its inclusion in Commission Implementing Regulation (EU) No 541/2011, which deemed prior approvals under Directive 91/414/EEC valid, with approval set to expire on 31 August 2026. The (EFSA) has reviewed existing maximum residue levels (MRLs) under Article 12 of Regulation (EC) No 396/2005, but due to unresolved concerns over the genotoxic potential of certain metabolites, no new MRL proposals were finalized; a default MRL of 0.01 mg/kg applies to commodities not explicitly listed. This conservative approach prioritizes consumer safety pending further data on residue definitions and toxicological reference values. The Joint FAO/WHO Meeting on Pesticide Residues (JMPR) has evaluated clethodim for in 1994 and 2019, establishing an (ADI) of 0–0.01 mg/kg body weight (bw) per day in 1994 based on a (NOAEL) of 1 mg/kg bw per day from a one-year dog , and revising it to 0–0.2 mg/kg bw per day in 2019 using a NOAEL of 16 mg/kg bw per day from a two-year rat . An acute reference dose (ARfD) was deemed unnecessary in both evaluations due to the absence of acute neurotoxic or reproductive effects at relevant doses. Residue evaluations occurred in 1997 and 2019 to support international MRL recommendations aligned with standards. Clethodim is approved for agricultural use in numerous countries worldwide, with registrations reported in over 40 nations as of earlier assessments, reflecting its broad adoption for grass weed control in broadleaf crops. It is not classified as highly hazardous under the (FSC) Pesticides Policy (FSC-POL-30-001), which evaluates risks based on criteria including WHO toxicity classes and environmental persistence, allowing its use in certified operations when applied per label instructions. In a recent review under the EPA's Endocrine Disruptor Screening Program (EDSP), completed as part of the 2025 registration review docket (interim decision June 2025), clethodim was assessed for potential endocrine-disrupting effects; no evidence of disruption to , , or pathways was identified in available data, supporting its continued eligibility without additional Tier 2 testing at this stage, with final decision pending. This determination aligns with prior toxicological profiles indicating low mammalian risk when used as directed.

Restrictions and Global Variations

In the , clethodim applications are subject to a restricted entry interval () of 24 hours, during which workers must not enter treated areas without appropriate . Labels also specify zones to protect habitats, with requirements varying by application method and location, often driven by ecotoxicological concerns for non-target organisms. In the , clethodim approval is set to expire on 31 August 2026, while in it holds approval under the GB Control of Pesticides Regulations (COPR), set to expire on 31 March 2027. As a synthetic , its use is prohibited in systems across these regions. Harmonization of maximum residue levels (MRLs) remains ongoing, with the (EFSA) having reviewed existing MRLs in 2019 to align them with updated toxicological data and standards. Prior to full EU-wide authorization in 2011, clethodim was not approved in approximately 12 of the then-27 member states, effectively restricting or prohibiting its use in those areas. In other regions, such as , permits clethodim at application rates up to 0.3 active ingredient per —higher than typical EU limits of 0.24 /—while implementing resistance monitoring programs due to increasing cases of resistant weeds like . Globally, resistance management follows Herbicide Resistance Action Committee (HRAC) guidelines, which mandate rotation of clethodim (HRAC , ACCase inhibitor) with herbicides of different modes of action to delay evolution in target grasses. Pre-harvest withdrawal periods for clethodim vary by crop and jurisdiction, generally ranging from 20 to 90 days; for instance, 90 days for and 60 days for soybeans in the .